Inventor · disambiguated record
Jooeun Bae
Also filed as: BAE JOOEUN
6 granted patents·6 pending applications·15 citations·filing 2007–2022
76Inventor score
Top patents by PatentIndex Score
12 records- 0185US9950047B2XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositionsDANA FARBER CANCER INST INC·Filed 2013·Granted Apr 24, 2018·9 cites·46 claims
- 0283US7901902B2Methods and compositions for identifying a cellular immune response against prostate cancerBIOSANTE PHARMACEUTICALS INC·Filed 2007·Granted Mar 8, 2011·3 cites·19 claims
- 0380US11517591B2Immunogenic peptides specific to BCMA and TACI antigensDANA FARBER CANCER INST INC·Filed 2018·Granted Dec 6, 2022·1 cites·38 claims
- 0477US9096681B2XBP1, CD138, and CS1 peptidesMUNSHI NIKHIL C·Filed 2009·Granted Aug 4, 2015·2 cites·11 claims
- 0568US2023248769A1Immunogenic peptides specific to bcma and taci antigens for treatment of cancerDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0666US2022031821A1Xbp1, cd138, and cs1 peptidesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0764US2021170004A1Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositionsDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0861US2025066738A1Induced pluripotent stem cells (ipsc), t-cell compositions and methods of useDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0959US11083783B2XBP1, CD138, and CS1 peptidesDANA FARBER CANCER INST INC·Filed 2015·Granted Aug 10, 2021·0 cites·24 claims
- 1059US2024285740A1Compositions and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1152US12448429B2T cell receptors specific to b-cell maturation antigen for treatment of cancerDANA FARBER CANCER INST INC·Filed 2020·Granted Oct 21, 2025·0 cites·11 claims
- 1250US2018133297A1Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositionsDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →